The study included adults aged 1875 with established UC diagnosis for 3 months, active disease with MS 5-10, MES 2, and inadequate response to conventional 5-ASA therapy, while excluding those with CD, toxic megacolon, recent biologic treatments, or risk of colectomy
Three subjects were excluded from all AUC 024h and C max Day 10 analyses: two withdrew from the trial before the 10th dose (one subject in each of the 2 hnight and night30 min treatment arms as described above) and one subject had an incomplete Day 10 pharmacokinetic profile (6 h30 min treatment arm)
[4] Research has found that carnitine supplementation supports a reduction in fatigue in hypothyroid patients, as well as improves muscle weakness for both hypo- and hyperthyroid patients
This titration phase is designed to reduce the severity of gastrointestinal side effects
Inborn errors in the metabolism of glutathione